From developments in CRISPR and drug pricing to revolutionary Covid treatments - all this and more: Just under one month left to join us on March 31 for this STAT Summit, and this year's lineup of speakers is one that you won't want to miss. They'll cover the ground-breaking work they're doing, whether it be in the lab or the boardroom, and how it's shaping the future of health and medicine. We'll examine what's next for Bristol Myers Squibb with Giovanni Caforio, M.D., the company's chairman and CEO. Annaliesa Anderson, Ph.D., chief scientific officer for bacterial vaccines and hospital at Pfizer and Charlotte Allerton, head of medicine design, at Pfizer, take the stage to discuss their efforts to develop an effective oral drug to treat Covid. And Alex Oshmyansky, M.D., Ph.D., founder and CEO of the Mark Cuban Cost Plus Drug Company, will join us to give insights into the company's efforts to reel in drug prices. There's more to come, so check out statnews.com/summit as we continue to release sessions! There, you'll also find more information about our featured speakers and see the agenda so far. Unlock your pass: Join the day from the comfort of your own laptop by purchasing virtual access with the Viewer Pass. Interested in being a part of the day in New York, live with our STAT team and the featured speakers? Apply for the Attendee Pass at checkout. If approved, you'll receive an invitation to the in-person event and access to the networking reception at the end of the day! Get Ticket Questions? Email us at summit@statnews.com. 
| 
No comments